Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMID 27015306)

Published in Cell on March 24, 2016

Authors

Srinivas Malladi1, Danilo G Macalinao2, Xin Jin1, Lan He1, Harihar Basnet1, Yilong Zou2, Elisa de Stanchina3, Joan Massagué4

Author Affiliations

1: Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
2: Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Gerstner Sloan Kettering Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
3: Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
4: Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: j-massague@ski.mskcc.org.

Articles citing this

Mechanism of early dissemination and metastasis in Her2(+) mammary cancer. Nature (2016) 1.08

Wnt signaling in cancer. Oncogene (2016) 0.95

Emerging Biological Principles of Metastasis. Cell (2017) 0.94

The complexity of integrins in cancer and new scopes for therapeutic targeting. Br J Cancer (2016) 0.81

Wnt Signaling in Cancer Stem Cell Biology. Cancers (Basel) (2016) 0.81

Meeting report: Metastasis Research Society-Chinese Tumor Metastasis Society joint conference on metastasis. Clin Exp Metastasis (2017) 0.80

Determinants of metastatic competency in colorectal cancer. Mol Oncol (2017) 0.80

In vivo models in breast cancer research: progress, challenges and future directions. Dis Model Mech (2017) 0.78

SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin. Sci Rep (2016) 0.76

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study. Front Immunol (2017) 0.76

CK1δ: an exploitable vulnerability in breast cancer. Ann Transl Med (2016) 0.75

Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis. Nat Cell Biol (2017) 0.75

Mouse genomic screen reveals novel host regulator of metastasis. Genome Biol (2017) 0.75

The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases. Breast Cancer Res Treat (2016) 0.75

CD59 Regulation by SOX2 Is Required for Epithelial Cancer Stem Cells to Evade Complement Surveillance. Stem Cell Reports (2016) 0.75

Properties and feasibility of using cancer stem cells in clinical cancer treatment. Cancer Biol Med (2016) 0.75

Means to the ends: The role of telomeres and telomere processing machinery in metastasis. Biochim Biophys Acta (2016) 0.75

Defining Metastatic Cell Latency. N Engl J Med (2016) 0.75

Precision medicine driven by cancer systems biology. Cancer Metastasis Rev (2017) 0.75

The Relationship Between Dormant Cancer Cells and Their Microenvironment. Adv Cancer Res (2016) 0.75

Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis. Cell (2017) 0.75

Orchestration of the crosstalk between astrocytes and cancer cells affects the treatment and prognosis of lung cancer sufferers with brain metastasis. J Thorac Dis (2016) 0.75

Adaptive Stress Responses During Tumor Metastasis and Dormancy. Trends Cancer (2016) 0.75

Targeting SOX9 for degradation to inhibit chemoresistance, metastatic spread, and recurrence. Mol Cell Oncol (2016) 0.75

Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15. Front Immunol (2016) 0.75

Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis. Oncogene (2017) 0.75

Molecular genetics and targeted therapy of WNT-related human diseases (Review). Int J Mol Med (2017) 0.75

Oligometastases of Gastrointestinal Cancer Origin. Visc Med (2017) 0.75

New insights into the role of EMT in tumor immune escape. Mol Oncol (2017) 0.75

Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers. Front Oncol (2017) 0.75

Tumor cell dormancy. Mol Oncol (2016) 0.75

Underlying Mechanisms for Distant Metastasis - Molecular Biology. Visc Med (2017) 0.75

Membrane-bound Dickkopf-1 in Foxp3(+) regulatory T cells suppresses T cell-mediated autoimmune colitis. Immunology (2017) 0.75

SOX2 Drives Bronchial Dysplasia in a Novel Organotypic Model of Early Human Squamous Lung Cancer. Am J Respir Crit Care Med (2017) 0.75

Articles cited by this

Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17

Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature (2009) 24.41

Identification of c-MYC as a target of the APC pathway. Science (1998) 24.25

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev (2003) 20.77

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol (2005) 9.76

The immunobiology of cancer immunosurveillance and immunoediting. Immunity (2004) 9.39

Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res (1992) 9.02

The Reactome pathway knowledgebase. Nucleic Acids Res (2013) 8.56

Coexistence of quiescent and active adult stem cells in mammals. Science (2010) 7.54

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet (2009) 7.48

Natural innate and adaptive immunity to cancer. Annu Rev Immunol (2011) 7.09

Interactions between cancer stem cells and their niche govern metastatic colonization. Nature (2011) 6.94

A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med (2005) 6.86

Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature (2014) 5.47

Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell (2009) 5.24

Slug and Sox9 cooperatively determine the mammary stem cell state. Cell (2012) 4.77

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet (2012) 4.70

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med (2011) 4.47

Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell (2011) 4.29

Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med (2011) 4.25

WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell (2009) 3.76

Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest (2010) 3.41

Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res (2010) 3.40

Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol (2007) 3.33

Suppression of lung adenocarcinoma progression by Nkx2-1. Nature (2011) 3.27

Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer (1998) 3.12

Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell (2014) 3.04

The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell (2013) 2.97

The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell (2012) 2.84

NCI series of cell lines: an historical perspective. J Cell Biochem Suppl (1996) 2.75

Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Reports (2013) 2.47

Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J Exp Med (2011) 2.38

Lentiviral vectors to probe and manipulate the Wnt signaling pathway. PLoS One (2010) 2.28

Does tumour dormancy offer a therapeutic target? Nat Rev Cancer (2010) 2.19

Immune cell promotion of metastasis. Nat Rev Immunol (2015) 2.15

Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer (2014) 2.09

Natural killer cells and cancer. Adv Cancer Res (2003) 1.99

Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. Elife (2014) 1.97

Cancer immunoediting by the innate immune system in the absence of adaptive immunity. J Exp Med (2012) 1.93

Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer (2002) 1.87

In vivo effect of anti-asialo GM1 antibody on natural killer activity. Nature (1981) 1.71

Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med (2003) 1.53

TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling. Nat Cell Biol (2013) 1.50

Cutting edge: viral infection breaks NK cell tolerance to "missing self". J Immunol (2008) 1.46

Balancing natural killer cell activation through paired receptors. Nat Rev Immunol (2015) 1.44

Wnt some lose some: transcriptional governance of stem cells by Wnt/β-catenin signaling. Genes Dev (2014) 1.33

Metastatic colonization by circulating tumour cells. Nature (2016) 1.31

The nude mouse: a model of deficient T-cell function. Methods Achiev Exp Pathol (1975) 1.25

NKG2D Receptor and Its Ligands in Host Defense. Cancer Immunol Res (2015) 1.25

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth. Cell Immunol (2001) 1.19

Risk factors for brain relapse in HER2-positive metastatic breast cancer patients. Breast Cancer Res Treat (2009) 1.14

SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC. Cell Death Differ (2011) 1.09

SOX2 regulates YAP1 to maintain stemness and determine cell fate in the osteo-adipo lineage. Cell Rep (2013) 1.07

Expression of SOX9 and SOX10 in central neuroepithelial tumor. J Neurooncol (2006) 1.00

Late recurrence of non-small cell lung cancer more than 5 years after complete resection: incidence and clinical implications in patient follow-up. Chest (2010) 0.95

Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cells. Blood (1998) 0.92

NK cell phenotypic modulation in lung cancer environment. PLoS One (2014) 0.85

Donor cancer transmission in kidney transplantation: a systematic review. Am J Transplant (2013) 0.84